#22 - Tom Dayspring, M.D., FACP, FNLA – Part III of V: HDL, reverse cholesterol transport, CETP inhibitors, and apolipoproteins
The Peter Attia Drive
00:00
The Inhibitor of Ctep Is Not Working
Peter: The failure of the black box warnng is one example of an over reaction too late. He says murk should have partitioned it and said, hey, maybe there's a subset of patients in whom we don't let this drug be ken. You can find all this information and more at peter t m d dot com. There you'll find the show notes, readings and linkhs related to this episode.
Transcript
Play full episode
